Critically ill patients with sepsis more likely to survive when given statins

• Research indicates that critically ill sepsis patients who receive statins may have a higher chance of survival.
• A study of 6,000 sepsis patients given statins showed 14.3 per cent died within 28 days, compared to 23.4 per cent of 6,000 patients who did not receive statins, equating to a 39% reduced risk of death.
• The study, conducted using data from a hospital in Israel between 2008 and 2019, also found lower mortality rates in intensive care and overall hospital stays for statin users.
• Dr. Caifeng Li, the study's corresponding author, suggested that statins may offer a protective effect and improve outcomes for sepsis patients.
• Dr. Ron Daniels, founder and chief executive of the UK Sepsis Trust, supports calls for larger trials to confirm the findings, noting the potential survival benefit from the anti-inflammatory properties of statins.

IN FULL

This common prescription drug could reduce deaths by sepsis, study finds